Integrating Bioinformatics and Machine Learning to Identify Glucose Metabolism-Related Biomarkers with Diagnostic and Prognostic Value for Patients with Kidney Renal Clear Cell Carcinoma

GRBs, including PFKP, pyruvate dehydrogenase kinase 1 (PDK1), and solute carrier family 2 member 1 (SLC2A1), demonstrated strong diagnostic and prognostic potential. PFKP emerged as a key therapeutic target, offering novel insights into predictive and treatment strategies for KIRC.